Mutations to the HCoV-229E spike have counterbalancing effects on serum antibody neutralization and receptor binding

Read full text
Authors: Sheri Harari, Rachel T. Eguia, Bernadeta Dadonaite, Caelan E. Radford, Cameron M. Stewart, David Veesler, Jesse D. Bloom
Cited by: 1

Abstract

Human coronavirus 229E (HCoV-229E) is an endemic pathogen that causes repeated "common-cold" infections throughout life. Like other coronaviruses, it accumulates spike mutations that erode antibody immunity and enable reinfection. Here, we use pseudovirus deep mutational scanning to measure how mutations to the HCoV-229E spike affect its cell entry function, binding to its human APN receptor, and neutralization by human sera with a range of sensitivities to erosion by viral evolution. We find that both receptor binding and serum neutralization are affected by mutations across spike, including many that modulate these properties by affecting the balance of up versus down conformations of the spike receptor-binding domain (RBD). In particular, some mutations increase both receptor binding and serum neutralization by shifting the RBD to a more up conformation, suggesting that the HCoV-229E spike has evolved to shield key RBD neutralizing epitopes at the cost of less efficient receptor binding.

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research Monoclonal and Polyclonal Antibodies Research Animal Virus Infections Studies

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Publication date
23 February 2026
Language
EN
Document type
Preprint